Xue Bai

Safety and clinical activity with an anti-PD-1 antibody JS001 in advanced melanoma or urologic cancer patients

Bixia Tang, Xieqiao Yan, Xinan Sheng et al. · Journal of Hematology & Oncology · 2019 · 188 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma

C. Owen, Xue Bai, Serigne Lo et al. · Annals of Oncology · 2021 · 184 citations · Full text

Medicine, Immunology, Oncology +14

Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti–PD-1 Monotherapy

Xue Bai, Jiani Hu, Allison Betof Warner et al. · Clinical Cancer Research · 2021 · 176 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients

Bin Lian, C-L. Cui, Li Zhou et al. · Annals of Oncology · 2016 · 170 citations

Medicine, Oncology, Surgery +16

Axitinib in Combination With Toripalimab, a Humanized Immunoglobulin G₄ Monoclonal Antibody Against Programmed Cell Death-1, in Patients With Metastatic Mucosal Melanoma: An Open-Label Phase IB Trial

Xinan Sheng, Xieqiao Yan, Zhihong Chi et al. · Journal of Clinical Oncology · 2019 · 169 citations · Full text

Medicine, Oncology, Pharmacology +17